Patents by Inventor Ajay Pandita

Ajay Pandita has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Genetic variations associated with drug resistance
    Patent number: 11021711
    Abstract: Methods and compositions are provided to determine if a cancer is resistant to treatment with anti-mitotic agents, including treatment with T-DM1. The methods relate to determining if the ABCC3 gene is amplified and/or overexpressed in the cancer.
    Type: Grant
    Filed: December 11, 2017
    Date of Patent: June 1, 2021
    Assignee: GENENTECH, INC.
    Inventors: Mark Lackner, Lukas C. Amler, Guy Cavet, Carol O'Brien, Ajay Pandita
  • GENETIC VARIATIONS ASSOCIATED WITH DRUG RESISTANCE
    Publication number: 20180298387
    Abstract: Methods and compositions are provided to determine if a cancer is resistant to treatment with anti-mitotic agents, including treatment with T-DM1. The methods relate to determining if the ABCC3 gene is amplified and/or overexpressed in the cancer.
    Type: Application
    Filed: December 11, 2017
    Publication date: October 18, 2018
    Inventors: Mark Lackner, Lukas C. Amler, Guy Cavet, Carol O'Brien, Ajay Pandita
  • Genetic variations associated with drug resistance
    Patent number: 9879267
    Abstract: Methods and compositions are provided to determine if a cancer is resistant to treatment with anti-mitotic agents, including treatment with T-DM1. The methods relate to determining if the ABCC3 gene is amplified and/or overexpressed in the cancer.
    Type: Grant
    Filed: March 12, 2009
    Date of Patent: January 30, 2018
    Assignee: Genentech, Inc.
    Inventors: Mark Lackner, Lukas C. Amler, Guy Cavet, Carol O'Brien, Ajay Pandita
  • GENETIC VARIATIONS ASSOCIATED WITH DRUG RESISTANCE
    Publication number: 20110177099
    Abstract: Methods and compositions are provided to determine if a cancer is resistant to treatment with anti-mitotic agents, including treatment with T-DM1. The methods relate to determining if the ABCC3 gene is amplified and/or overexpressed in the cancer.
    Type: Application
    Filed: March 12, 2009
    Publication date: July 21, 2011
    Inventors: Mark Lackner, Lukas C. Amler, Guy Cavet, Carol O'Brien, Ajay Pandita